Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP news

Show

From To
David Cameron, Nick Clegg and Ed Miliband praise HIV prevention drug PrEP

The three main political party leaders in the UK have all praised the HIV prevention drug PrEP, during a Q&A for GT (Gay Times) Magazine.

Published
12 hours ago
From
Pink News
Pre-exposure prophylaxis works—it's time to deliver

The science is now clear: oral pre-exposure prophylaxis (PrEP) with a coformulation of tenofovir disoproxil fumarate and emtricitabine (Truvada) significantly reduces the risk of HIV infection among individuals at high risk of HIV infection. The news that PrEP has shown consistent efficacy among those who take it as prescribed should be a cause for celebration, and galvanise action to ensure access to PrEP for those who could benefit the most.

Published
17 April 2015
From
The Lancet
Are Condoms Over? Research and Reality for Gay Men

Are condoms over? No. The availability of new prevention options does not require us to abandon a tool that has been proven effective for decades. Let's move forward in the search for new prevention options without bashing the ones we have -- or those who promote them.

Published
15 April 2015
From
The Body
Revolutionary PrEP program in Illinois halted by governor before launch

In December 2014 the Illinois Department of Public Health (IDPH) publicly unveiled a program aimed at increasing access to the drug Truvada for pre-exposure prophylaxis (PrEP) to help HIV-negative people remain uninfected. But shortly after Governor Bruce Rauner took office, he issued an Executive Order that halted all “nonessential” spending in Illinois, which included PrEP4Illinois.

Published
12 April 2015
From
AIDS Chicago
Women in PrEP trial feared they would have to leave study if they reported low adherence

Post-study interviews and computer questionnaires conducted with former participants in a trial of pre-exposure prophylaxis (PrEP) that reported zero effectiveness show that participants concealed their low adherence to

Published
10 April 2015
By
Gus Cairns
HIV prevention within serodiscordant couples: A changing paradigm

Serodiscordant couples (where one partner is HIV negative and the other is HIV positive) are often thought to be at “high risk” of HIV transmission. However, new understandings of the biology of HIV transmission and the emergence of new HIV prevention options mean that the HIV transmission risk within these couples can be reduced to very low, even negligible levels.

Published
07 April 2015
From
CATIE
Providers have mixed feelings about prescribing HIV prevention

National survey finds providers’ perspectives lag behind PrEP guidelines: The survey was the first to be conducted since the U.S. Public Health Service released detailed PrEP guidelines in May 2014. In the Web-based survey fewer than half of 324 practitioners, most of them HIV specialists, fewer than half reported being “very likely” to prescribe PrEP to their patients who are high-risk heterosexuals or people who use intravenous drugs. For some other prime candidates—HIV-negative men whose male partners have the virus—79 percent of providers reported being very likely to prescribe the regimen.

Published
07 April 2015
From
Group Health Research Institute
CDC leading new efforts to fight HIV among gay, bisexual men and transgender people

The Centers for Disease Control and Prevention will lead new programs totaling more than $185 million in HIV prevention funding for men who have sex with men (MSM) and transgender people, with a particular focus on addressing the needs of MSM of color. Up to $125 million will help state and local health departments expand the use of two new, powerful HIV prevention strategies: pre-exposure prophylaxis (PrEP) and engaging more people in HIV care.

Published
07 April 2015
From
CDC press release
Positively UK’s Statement on PrEP

Positively UK welcomes the findings from PROUD and IPERGAY studies, which demonstrate the high effectiveness of usingPre-Exposure Prophylaxis (PrEP) as an effective tool for HIV prevention and promoting the health of gay men and men who have sex with men. Positively UK joins other UK based HIV and LGBT organisations in urging the NHS to speed up the approval process and make PrEP available.

Published
01 April 2015
From
Positively UK
Our HIV crisis: PrEP is not a cure

Take a pill daily and prevent the contraction of HIV 99 percent of the time. That is the narrative presented to many young men who have sex with men (MSM) by their peers regarding pre-exposure prophylaxis (PrEP). And, as is normally the case with anything framed in such a simple manner, the nuances of treatment fall through the cracks. It is unwise to herald PrEP as the key to freeing a generation from HIV. It is merely one piece of a larger effort. Not only is PrEP not for everyone, but public health activists face political obstacles similar to those hurled at advocates of birth control.

Published
01 April 2015
From
Yale Daily News
← First12345...54Next →

Filter by country